AI assistant
Citadel Group — Director's Dealing 2020
Jul 28, 2020
10454_mrq_2020-07-28_081d8f3e-2587-4848-9c2e-80df878cea3f.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 3635U
Citadel Group
28 July 2020
Ap 19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1)
Citadel Group
Company dealt in
WILLIS TOWERS WATSON PLC
Class of relevant security to which the dealings being disclosed relate (Note 2)
Common Stock ISIN IE00BDB6Q211
Date of dealing
27 July, 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 3)
| Long | Short | |
| Common Stock ISIN IE00BDB6Q211 | Number (%) | Number (%) |
| (1) Relevant securities | 398,936 (0.31%) | 1,766 (0.00%) |
| (2) Derivatives (other than options) | 1,206,025 (0.94%) | 0 (0.00%) |
| (3) Options and agreements to purchase/sell | 0 (0.00%) | 0 (0.00%) |
| Total | 1,604,961(1.25%) | 1,766 (0.00%) |
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
| Long | Short | |
| Number (%) | Number (%) | |
| (1) Relevant securities | ||
| (2) Derivatives (other than options) | ||
| (3) Options and agreements to purchase/sell | ||
| Total |
Ap 20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale Common Stock ISIN IE00BDB6Q211 |
Number of securities | Price per unit (Note 5) |
| Purchase | 121 | 210.56826446 USD |
| Purchase | 25 | 211.02 USD |
| Purchase | 105 | 211.06952381 USD |
| Purchase | 6 | 211.24 USD |
| Purchase | 18 | 211.51 USD |
| Purchase | 50 | 211.54 USD |
| Purchase | 133 | 211.6062406 USD |
| Sale | -100 | 210.78 USD |
| Sale | -100 | 210.86 USD |
| Sale | -410 | 210.90217073 USD |
| Sale | -200 | 210.94 USD |
| Sale | -22 | 210.94363636 USD |
| Sale | -1,504 | 211.2475133 USD |
| Sale | -93 | 211.27075269 USD |
| Sale | -164 | 211.47146341 USD |
| Sale | -368 | 211.66182065 USD |
| Sale | -110 | 211.99818182 USD |
(b) Derivatives transactions (other than options transactions)
| Product name, e.g. CFD Common Stock ISIN IE00BDB6Q211 |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
| CFD | Increasing long position | 14,754 | 211.16803 USD |
| CFD | Increasing long position | 24,061 | 211.427452 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
| Product name, e.g. call option | Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. |
Expiry date | Option money paid/ received per unit (Note 5) |
(ii) Exercising
| Product name, e.g. call option |
Number of securities | Exercise price per unit (Note 5) |
(d) Other dealings (including transactions in respect of new securities) (Note 4)
| Nature of transaction (Note 8) |
Details | Price per unit (if applicable) (Note 5) |
Ap 21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated |
| None |
Is a Supplemental Form 8 attached? (Note 9)
NO
| Date of disclosure: | 28 July, 2020 |
| Contact name: | Katie Bonds |
| Telephone number: | 020 7645 9700 |
| If a connected EFM, name of offeree/offeror with which connected | n/a |
| If a connected EFM, state nature of connection (Note 10) | n/a |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
ISEPPUQGMUPUGPR